Catalyst Biosciences Inc buy Guggenheim
Start price
21.01.26
/
50%
€0.52
Target price
21.01.27
€29.84
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 21.01.27. The prediction end date can be changed by Guggenheim at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Biosciences Inc | - | - |
| iShares Core DAX® | 0.751% | -8.496% |
| iShares Nasdaq 100 | -1.405% | -2.771% |
| iShares Nikkei 225® | 0.417% | -9.291% |
| iShares S&P 500 | -0.590% | -2.868% |
Comments by Guggenheim for this prediction
In the thread Catalyst Biosciences Inc diskutieren
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating and a $35.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat